Authors: Berntorp, E Petrini, P Dockter, G Tengborn, L Wendisch, I Eberl, W Aumann, V Frade, G Seliger, I Engl, W Ehrlich, H

Citation: E. Berntorp et al., An approach to study the viral safety of plasma-derived products in previously treated, non-infected patients, HAEMOPHILIA, 7(4), 2001, pp. 360-363

Authors: Chapel, HM Spickett, GP Ericson, D Engl, W Eibl, MM Bjorkander, J

Citation: Hm. Chapel et al., The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy, J CLIN IMM, 20(2), 2000, pp. 94-100

Authors: Goebel, FD Mannhalter, JW Belshe, RB Eibl, MM Grob, PJ de Gruttolae, V Griffiths, PD Erfle, V Kunschak, M Engl, W

Citation: Fd. Goebel et al., Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of alarge randomized, controlled trial, AIDS, 13(12), 1999, pp. 1461-1468